Here’s a good article by Adam Piore on some of the ways anti-aging scientists are being funded.
From MIT Tech Review: “The treatment is different than any that’s come before because it appears to be an outright cure carried out through a genetic repair. The therapy was tested on 18 children, the first of them 15 years
Lucky mice. Time will tell if it matters for humans. Here’s the study. And the Newsweek write up on it.
Another great article by the WAPO’s Ariana Eunjug Cha. Here’s a small excerpt from the piece: “As a tidal wave of new health-related gadgets, apps and tests hits the market, government agencies like the FDA, Federal Trade Commission and others
Note that the results are for mice only (so far). Human trials are coming soon. Here’s the University press release. And the news story. “Researchers have discovered that an injection of a protein called IL-33 can reverse Alzheimer’s-like symptoms and
From the Washington Post. “Scientists reported Tuesday on two new studies showing that the medications, which marshal the body’s own immune defenses, are now proving effective against recurrent, difficult-to-treat head and neck cancer and an extremely lethal skin cancer called
Here’s some interesting news from The Scripps Research Institute (TSRI) and the Mayo Clinic. Researchers found that a combination of two drugs — cancer drug dasatinib and quercetin — “dramatically slows the aging process (in animal models)—alleviating symptoms of frailty,
Looking forward to seeing how this rolls out next year! Read the story here and here.
It’s not a cure, but it’s a start towards one. From the NYT: “Five years ago, a college freshman named Ian Burkhart dived into a wave at a beach off the Outer Banks in North Carolina and, in a freakish
A new study shows that, for a small number of lucky individuals, it is possible to have a faulty gene that causes severe disease and not get that disease (think cystic fibrosis, etc). The problem though is that researchers don’t
From the Telegraph: “Researchers from Orlando Health in Florida detected a biomarker released by the brain during injury. They found that the biomarker can stay in the bloodstream for up to a week – which means patients who suffer delayed
Here it is — the $1000 whole genome. Veritas Genetics is co-founded by Harvard Medical School professor and genetics pioneer Dr. George Church. The company first broke the $1,000 genome barrier in 2015 when it made whole genome sequencing available
Here’s a neat idea reported on by The Scientist. “Five years ago, scientists at the Memorial Sloan Kettering Cancer Center in New York City showed that circulating tumor cells (CTCs) could both colonize new metastases and travel back to their
The idea behind the company is to expel toxic, worn-out cells called “senescent cells.” Here’s the story in Fortune.
From STAT NEWS: The long-running Framingham Heart Study has found that “the rate of dementia was 3.6 percent in the late 1970s and early 1980s, falling to 2.8 percent a decade later, 2.2 percent a decade after that, and 2
The Economist has a good story on the progress being made in cryobanking. Read the story here.
Remember the horrific Thalidomide disaster when babies were being born without limbs? Well, turns out the drug might have a happier purpose. Researchers have figured out how to use it to bioengineer a way to kill cancer. Here’s the story.
From TechCrunch: “From Google[x]’s cancer-seeking nanopills to Atomwise, a machine-learning platform working on finding the cure to orphan diseases, the Bay Area offers several startups and organizations coming at the problem in a different way.Incubators such as Y Combinator, IndieBio
Here’s the story in Forbes: “What if a simple blood test could detect any cancer early, when it was still easy to treat? It sounds like science fiction. But Illumina ILMN -0.61%, the $24 billion (market cap) biotechnology company that
Here is the list.